Thyrocare Technologies Ltd
NSE:THYROCARE

Watchlist Manager
Thyrocare Technologies Ltd Logo
Thyrocare Technologies Ltd
NSE:THYROCARE
Watchlist
Price: 449.85 INR -0.8%
Market Cap: ₹71.6B

Net Margin

16.7%
Current
Improving
by 3.5%
vs 3-y average of 13.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
16.7%
=
Net Income
₹1.3B
/
Revenue
₹7.6B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
16.7%
=
Net Income
₹1.3B
/
Revenue
₹7.6B

Peer Comparison

Country Company Market Cap Net
Margin
IN
Thyrocare Technologies Ltd
NSE:THYROCARE
71.8B INR
Loading...
US
CVS Health Corp
NYSE:CVS
90.2B USD
Loading...
US
Cigna Group
XMUN:CGN
63B EUR
Loading...
US
Cigna Corp
NYSE:CI
72.3B USD
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.6B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.8B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.3B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.4B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14.3B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.1B AUD
Loading...

Market Distribution

Higher than 80% of companies in India
Percentile
80th
Based on 5 531 companies
80th percentile
16.7%
Low
-305 007.7% — 2.1%
Typical Range
2.1% — 11.6%
High
11.6% — 1 221 633.3%
Distribution Statistics
India
Min -305 007.7%
30th Percentile 2.1%
Median 5.8%
70th Percentile 11.6%
Max 1 221 633.3%

Thyrocare Technologies Ltd
Glance View

Market Cap
71.6B INR
Industry
Health Care

Thyrocare Technologies Ltd. engages in provison of indepedent diagnostic and pathological laboratory services. The company is headquartered in Navi Mumbai, Maharashtra and currently employs 2,115 full-time employees. The company went IPO on 2016-05-09. The firm operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The firm offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The firm offers various kinds of tests, such as Aarogyam X, Aarogyam XL, Aarogyam 1.1, Aarogyam 1.2 and Covid Antibody GT. The company also offers Thyroxine (T4), Triiodothyronine (T3), Thyroid-stimulating hormone and Complete Vitamin Profile tests.

THYROCARE Intrinsic Value
236.6 INR
Overvaluation 47%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
16.7%
=
Net Income
₹1.3B
/
Revenue
₹7.6B
What is Thyrocare Technologies Ltd's current Net Margin?

The current Net Margin for Thyrocare Technologies Ltd is 16.7%, which is above its 3-year median of 13.2%.

How has Net Margin changed over time?

Over the last 3 years, Thyrocare Technologies Ltd’s Net Margin has increased from 15.6% to 16.7%. During this period, it reached a low of 11.2% on Jun 30, 2023 and a high of 16.7% on Sep 30, 2025.

Back to Top